• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCR-5的多个细胞外结构域有助于1型人类免疫缺陷病毒的进入和融合。

Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.

作者信息

Picard L, Simmons G, Power C A, Meyer A, Weiss R A, Clapham P R

机构信息

Chester Beatty Laboratories, Institute of Cancer Research, London, United Kingdom.

出版信息

J Virol. 1997 Jul;71(7):5003-11. doi: 10.1128/JVI.71.7.5003-5011.1997.

DOI:10.1128/JVI.71.7.5003-5011.1997
PMID:9188565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC191733/
Abstract

Human immunodeficiency virus type 1 (HIV-1) entry is governed by the interaction of the viral envelope glycoprotein (Env) with its receptor. The HIV-1 receptor is composed of two molecules, the CD4 binding receptor and a coreceptor. The seven-membrane-spanning chemokine receptor CCR-5 is one of the coreceptors used by primary isolates of HIV-1. We demonstrate that the mouse homolog of CCR-5 (mCCR-5) does not function as an HIV-1 coreceptor. A set of chimeras of human CCR-5 and mCCR-5 was studied for Env-induced cell fusion and HIV-1 infection. Using the HIV-1ADA envelope glycoprotein in a syncytium formation assay, we show that replacement of any fragment containing extracellular domains of mCCR-5 by its human counterparts is sufficient to allow Env-induced fusion. Conversely, replacement of any fragment containing human extracellular domains by its murine counterpart did not lead to coreceptor function loss. These results show that several domains of CCR-5 participate in coreceptor function. In addition, using a panel of primary nonsyncytium-inducing and syncytium-inducing isolates that use CCR-5 or both CXCR-4 and CCR-5 as coreceptors, we show that the latter dual-tropic isolates are less tolerant to changes in CCR-5 than strains with a more restricted coreceptor use. Thus, different strains are likely to have different ways of interacting with the CCR-5 coreceptor.

摘要

1型人类免疫缺陷病毒(HIV-1)的进入受病毒包膜糖蛋白(Env)与其受体相互作用的调控。HIV-1受体由两个分子组成,即CD4结合受体和一个共受体。七跨膜趋化因子受体CCR-5是HIV-1原始分离株使用的共受体之一。我们证明CCR-5的小鼠同源物(mCCR-5)不能作为HIV-1共受体发挥作用。研究了一组人CCR-5和mCCR-5的嵌合体在Env诱导的细胞融合和HIV-1感染方面的情况。在合胞体形成试验中使用HIV-1ADA包膜糖蛋白,我们发现用其人类对应物替换包含mCCR-5细胞外结构域的任何片段足以允许Env诱导的融合。相反,用其小鼠对应物替换包含人类细胞外结构域的任何片段不会导致共受体功能丧失。这些结果表明CCR-5的几个结构域参与共受体功能。此外,使用一组以CCR-5或同时以CXCR-4和CCR-5作为共受体的原发性非合胞体诱导型和合胞体诱导型分离株,我们发现后者的双嗜性分离株对CCR-5变化的耐受性低于共受体使用更受限的毒株。因此,不同的毒株可能与CCR-5共受体有不同的相互作用方式。

相似文献

1
Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.CCR-5的多个细胞外结构域有助于1型人类免疫缺陷病毒的进入和融合。
J Virol. 1997 Jul;71(7):5003-11. doi: 10.1128/JVI.71.7.5003-5011.1997.
2
Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates.多个残基导致小鼠CCR-5无法作为嗜巨噬细胞性1型人类免疫缺陷病毒分离株的共受体发挥作用。
J Virol. 1998 Mar;72(3):1918-24. doi: 10.1128/JVI.72.3.1918-1924.1998.
3
HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor.HIV-1诱导的细胞融合由病毒包膜和CCR-5共受体中的多个区域介导。
EMBO J. 1997 May 15;16(10):2599-609. doi: 10.1093/emboj/16.10.2599.
4
Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.1型和2型人类免疫缺陷病毒以及猿猴免疫缺陷病毒的包膜糖蛋白可将人类CCR5用作病毒进入的共受体,并与这种趋化因子受体进行直接的CD4依赖性相互作用。
J Virol. 1997 Sep;71(9):6296-304. doi: 10.1128/JVI.71.9.6296-6304.1997.
5
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.CD4诱导的原发性HIV-1 gp120糖蛋白与趋化因子受体CCR-5的相互作用。
Nature. 1996 Nov 14;384(6605):179-83. doi: 10.1038/384179a0.
6
Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.CXCR-4的第一和第三个细胞外结构域在人类免疫缺陷病毒共受体活性中的作用。
J Virol. 1997 Jun;71(6):4744-51. doi: 10.1128/JVI.71.6.4744-4751.1997.
7
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.原发性患者和实验室适应性1型人类免疫缺陷病毒分离株感染对CD4、CXCR-4和CCR-5的依赖性
J Virol. 1997 Feb;71(2):873-82. doi: 10.1128/JVI.71.2.873-882.1997.
8
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.两个不同的CCR5结构域可介导1型人类免疫缺陷病毒的共受体使用。
J Virol. 1997 Sep;71(9):6305-14. doi: 10.1128/JVI.71.9.6305-6314.1997.
9
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.由包膜V3环内的单个氨基酸决定的趋化因子受体作为1型人类免疫缺陷病毒共受体的选择性应用。
J Virol. 1997 Sep;71(9):7136-9. doi: 10.1128/JVI.71.9.7136-7139.1997.
10
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.基因差异的猿猴免疫缺陷病毒株将CCR5用作进入细胞的共受体。
J Virol. 1997 Apr;71(4):2705-14. doi: 10.1128/JVI.71.4.2705-2714.1997.

引用本文的文献

1
Evolution of coreceptor utilization to escape CCR5 antagonist therapy.共受体利用情况的演变以逃避CCR5拮抗剂治疗。
Virology. 2016 Jul;494:198-214. doi: 10.1016/j.virol.2016.04.010. Epub 2016 Apr 26.
2
Statistical correlation of nonconservative substitutions of HIV gp41 variable amino acid residues with the R5X4 HIV-1 phenotype.HIV gp41可变氨基酸残基的非保守性替换与R5X4 HIV-1表型的统计相关性。
Virol J. 2016 Feb 16;13:28. doi: 10.1186/s12985-016-0486-6.
3
Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1.简短通讯:利用小鼠CCR5的HIV-1变体揭示了gp120的V3冠与CCR5细胞外环1的关键相互作用。
AIDS Res Hum Retroviruses. 2015 Oct;31(10):992-8. doi: 10.1089/AID.2015.0131. Epub 2015 Aug 5.
4
HIV-1 Entry, Inhibitors, and Resistance.HIV-1 进入、抑制剂和耐药性。
Viruses. 2010 May;2(5):1069-1105. doi: 10.3390/v2051069. Epub 2010 Apr 29.
5
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.趋化因子及其受体 CXCR4 和 CCR5 在人类疾病中的生物学和临床意义。
Exp Biol Med (Maywood). 2011 Jun 1;236(6):637-47. doi: 10.1258/ebm.2011.010389. Epub 2011 May 12.
6
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.一种对马拉维若耐药的 HIV-1 对其他 CCR5 拮抗剂的交叉耐药性较窄,这取决于药物结合的 CCR5 的 N 端和细胞外环结构域。
J Virol. 2010 Oct;84(20):10863-76. doi: 10.1128/JVI.01109-10. Epub 2010 Aug 11.
7
Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.X4 嗜性的人类免疫缺陷病毒 1 型 V3 截短株通过不同的分子途径,导致不同的核心受体相互作用和对 CXCR4 拮抗剂的敏感性。
J Virol. 2010 Sep;84(17):8777-89. doi: 10.1128/JVI.00333-10. Epub 2010 Jun 23.
8
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.七跨膜受体作为构象变化蛋白:变构调节和功能选择性对新药发现的影响。
Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14.
9
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.一名对CCR5拮抗剂具有基线耐药性的患者的1型艾滋病毒利用与药物结合的受体进入细胞。
AIDS Res Hum Retroviruses. 2010 Jan;26(1):13-24. doi: 10.1089/aid.2009.0132.
10
Allosteric theory: taking therapeutic advantage of the malleable nature of GPCRs.变构理论:利用 G 蛋白偶联受体的可塑本质发挥治疗优势。
Curr Neuropharmacol. 2007 Sep;5(3):149-56. doi: 10.2174/157015907781695973.

本文引用的文献

1
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.一种新型CCR5拮抗剂对巨噬细胞和淋巴细胞中HIV-1感染性的强效抑制作用。
Science. 1997 Apr 11;276(5310):276-9. doi: 10.1126/science.276.5310.276.
2
Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).人类免疫缺陷病毒毒株在感染表达CXCR - 4(融合素)大鼠同源物的CD4 +细胞的能力上存在差异。
J Virol. 1997 Apr;71(4):3259-62. doi: 10.1128/JVI.71.4.3259-3262.1997.
3
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.基因差异的猿猴免疫缺陷病毒株将CCR5用作进入细胞的共受体。
J Virol. 1997 Apr;71(4):2705-14. doi: 10.1128/JVI.71.4.2705-2714.1997.
4
Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.共受体使用情况的变化与HIV-1感染个体的疾病进展相关。
J Exp Med. 1997 Feb 17;185(4):621-8. doi: 10.1084/jem.185.4.621.
5
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.致病性猿猴免疫缺陷病毒SIVmac239的包膜糖蛋白对C-C趋化因子受体5的利用
J Virol. 1997 Mar;71(3):2522-7. doi: 10.1128/JVI.71.3.2522-2527.1997.
6
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia.CCR3和CCR5是小胶质细胞被HIV-1感染的共受体。
Nature. 1997 Feb 13;385(6617):645-9. doi: 10.1038/385645a0.
7
HIV-1 tropism and co-receptor use.HIV-1嗜性及共受体利用情况。
Nature. 1997 Feb 6;385(6616):495-6. doi: 10.1038/385495a0.
8
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.原发性患者和实验室适应性1型人类免疫缺陷病毒分离株感染对CD4、CXCR-4和CCR-5的依赖性
J Virol. 1997 Feb;71(2):873-82. doi: 10.1128/JVI.71.2.873-882.1997.
9
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.对β趋化因子抑制作用的敏感性与原发性HIV-1分离株的生物学表型相关。
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15382-7. doi: 10.1073/pnas.93.26.15382.
10
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.原发性、诱导合胞体的1型人类免疫缺陷病毒分离株具有双嗜性,大多数可使用Lestr或CCR5作为病毒进入的共受体。
J Virol. 1996 Dec;70(12):8355-60. doi: 10.1128/JVI.70.12.8355-8360.1996.